S100A4 Polyklonaler Antikörper

• Featured Product
• KD/KO Validated

S100A4 Polyklonal Antikörper für FC, IF, IHC, WB, ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus und mehr (2)

Anwendung

WB, IP, IHC, IF, FC, ELISA

Konjugation

Unkonjugiert

Publikationen

49

Kat-Nr. : 16105-1-AP

Synonyme

18A2, 42A, Calvasculin, CAPL, Fibroblast Specific Protein, Fibroblast-specific protein 1, FSP1, FSP-1, Metastasin, MTS1, P9KA, PEL98, Protein Mts1, Protein S100 A4, S100A4

---

Galerie der Validierungsdaten

• 

  WB analysis using 16105-1-AP

  Various lysates were subjected to SDS PAGE followed by western blot with 16105-1-AP (S100A4 antibody) at dilution of 1:30000 incubated at room temperature for 1.5 hours.

• 

  WB analysis of HeLa using 16105-1-AP

  WB result of S100A4 antibody (16105-1-AP; 1:200000; incubated at room temperature for 1.5 hours) with sh-Control and sh-S100A4 transfected HeLa cells.

• 

  IHC staining of human breast cancer using 16105-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 16105-1-AP (S100A4 Antibody) at dilution of 1:200 (under 10x lens).

• 

  IHC staining of human breast cancer using 16105-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer tissue slide using 16105-1-AP (S100A4 Antibody) at dilution of 1:200 (under 40x lens).

• 

  IHC staining of human colon cancer using 16105-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon cancer tissue slide using 16105-1-AP (S100A4 Antibody) at dilution of 1:200 (under 10x lens).

• 

  IHC staining of human colon cancer using 16105-1-AP

  Immunohistochemical analysis of paraffin-embedded human colon cancer tissue slide using 16105-1-AP (S100A4 Antibody) at dilution of 1:200 (under 40x lens).

• 

  IHC staining of human breast cancer using 16105-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 16105-1-AP (S100A4 antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human breast cancer using 16105-1-AP

  Immunohistochemical analysis of paraffin-embedded human breast cancer using 16105-1-AP (S100A4 antibody) at dilution of 1:50 (under 40x lens).

• 

  IHC staining of human pancreas cancer using 16105-1-AP

  Immunohistochemical analysis of paraffin-embedded human pancreas cancer using 16105-1-AP (S100A4 antibody) at dilution of 1:50 (under 10x lens).

• 

  IHC staining of human pancreas cancer using 16105-1-AP

  Immunohistochemical analysis of paraffin-embedded human pancreas cancer using 16105-1-AP (S100A4 antibody) at dilution of 1:50 (under 40x lens).

• 

  IF Staining of HeLa using 16105-1-AP

  Immunofluorescent analysis of (4% PFA) fixed HeLa cells using S100A4 antibody (16105-1-AP) at dilution of 1:400 and CoraLite®488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L), CL594-Phalloidin (red).

• 

  FC experiment of HeLa using 16105-1-AP

  1X10^6 HeLa cells were intracellularly stained with 0.4 ug Anti-Human S100A4 (16105-1-AP) and CoraLite®488-Conjugated AffiniPure Goat Anti-Rabbit IgG(H+L) at dilution 1:1000 (red), or 0.4 ug Control Antibody. Cells were fixed with 4% PFA and permeabilized with Flow Cytometry Perm Buffer (PF00011-C).

---

Geprüfte Anwendungen

• Erfolgreiche Detektion in WB: A549-Zellen, HeLa-Zellen, NIH/3T3-Zellen
• Erfolgreiche Detektion in IHC: humanes Mammakarzinomgewebe, humanes Kolonkarzinomgewebe, humanes Pankreaskarzinomgewebe; Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.
• Erfolgreiche Detektion in IF: HeLa-Zellen
• Erfolgreiche Detektion in FC: HeLa-Zellen

Empfohlene Verdünnung

• Western Blot (WB): WB : 1:5000-1:50000
• Immunhistochemie (IHC): IHC : 1:50-1:500
• Immunfluoreszenz (IF): IF : 1:200-1:800
• Durchflusszytometrie (FC): FC : 0.40 ug per 10^6 cells in a 100 µl suspension

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

• KD/KO: See 3 publications below
• WB: See 26 publications below
• IHC: See 13 publications below
• IF: See 25 publications below
• IP: See 1 publications below

Produktinformation

16105-1-AP bindet in WB, IP, IHC, IF, FC, ELISA S100A4 und zeigt Reaktivität mit human, Maus

• Getestete Reaktivität: human, Maus
• In Publikationen genannte Reaktivität: human, Hausschwein, Maus, Ratte
• Wirt / Isotyp: Kaninchen / IgG
• Klonalität: Polyklonal
• Typ: Antikörper
• Immunogen: S100A4 fusion protein Ag9019
• Vollständiger Name: S100 calcium binding protein A4
• Berechnetes Molekulargewicht: 101 aa, 12 kDa
• Beobachtetes Molekulargewicht: 10-12 kDa
• GenBank-Zugangsnummer: BC016300
• Gene symbol: S100A4
• Gene ID (NCBI): 6275
• Konjugation: Unkonjugiert
• Form: Liquid
• Reinigungsmethode: Antigen-Affinitätsreinigung
• Lagerungspuffer: PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
• Lagerungsbedingungen: Bei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20^oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

S100A4 is a member of the S100 family of calcium-binding proteins. The S100 family members have been involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100A4 is known to localize to and function in the nucleus, cytoplasm of cells, and the extracellular space. S100A4 has also been shown to be associated with tumor growth, motility, invasion, metastasis, angiogenesis, apoptosis, and chemoresistance. It is a fibroblast-specific protein associated with mesenchymal cell morphology and motility, is expressed during epithelial-mesenchymal transformations (EMT) in vivo (PMID: 9362334). It is a specific prognostic marker for renal survival in patients with IgAN (PMID: 16105038). It is also an improved marker for lung fibroblasts that could be useful for investigating the pathogenesis of pulmonary fibrosis(PMID: 15618458). Overexpression of S100A4 is correlated with a worse prognosis inpatients with various types of cancer.

Publikationen

Species	Application	Title
human	WB	Cell; Suppression of Enhancer Overactivation by a RACK7-Histone Demethylase Complex.; Authors - Hongjie Shen ; KO Validated
human	IHC	J Hematol Oncol; Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma; Authors - Yexin Tong
human	WB	Nat Commun; Co-evolution of matrisome and adaptive adhesion dynamics drives ovarian cancer chemoresistance.; Authors - Elina A Pietilä
mouse	WB	ACS Appl Mater Interfaces; Smart Manganese Dioxide-Based Lanthanide Nanoprobes for Triple-Negative Breast Cancer Precise Gene Synergistic Chemodynamic Therapy.; Authors - Liyan Ming
human	WB,IF	Oncogene; Stromal nicotinamide N-methyltransferase orchestrates the crosstalk between fibroblasts and tumour cells in oral squamous cell carcinoma: evidence from patient-derived assembled organoids; Authors - Hui Zhao
human	IF	J Crohns Colitis; Exosomal miR-103a-3p from Crohn's creeping fat-derived ASCs contributes to intestinal fibrosis by targeting TGFBR3 and activating fibroblasts; Authors - Wenwei Qian

Verwandte Produkte

Flow Cytometry Perm Buffer (10X)

PF00011-C

P53 Polyclonal antibody

10442-1-AP

S100 Beta Polyclonal antibody

15146-1-AP

MYH9 Polyclonal antibody

11128-1-AP

S100A6 Polyclonal antibody

10245-1-AP

S100A6 Monoclonal antibody

66098-1-Ig

E-cadherin Polyclonal antibody

20874-1-AP

E-cadherin Monoclonal antibody

60335-1-Ig

S100 Beta Polyclonal antibody

15146-1-AP

MMP2 Polyclonal antibody

10373-2-AP

NOV Polyclonal antibody

55449-1-AP